Start SIP in CAMLINFINE
Start SIPPerformance
- Low
- ₹124
- High
- ₹129
- 52 Week Low
- ₹80
- 52 Week High
- ₹140
- Open Price₹124
- Previous Close₹125
- Volume2,236,977
Investment Returns
- Over 1 Month + 2.86%
- Over 3 Month + 17.82%
- Over 6 Month + 12.54%
- Over 1 Year -4.01%
Smart Investing Starts Here Start SIP with Camlin Fine Sciences for Steady Growth!
Camlin Fine Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.4
- PEG Ratio
- 0
- Market Cap Cr
- 2,096
- P/B Ratio
- 2.6
- Average True Range
- 5.58
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- 2.52
- RSI
- 61.16
- MFI
- 74.55
Camlin Fine Sciences Financials
Camlin Fine Sciences Technicals
EMA & SMA
Current Price
₹125.12
+
0.55
(0.44%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹120.40
- 50 Day
- ₹115.67
- 100 Day
- ₹112.37
- 200 Day
- ₹113.82
Resistance and Support
126
- R3 133.40
- R2 131.23
- R1 128.17
- S1 122.94
- S2 120.77
- S3 117.71
Camlin Fine Sciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-22 | Rights issue of Equity Shares | Rs.0.00 alia, to consider : 1. The revision of the quantum of the proposed Rights isue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company. |
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-20 | Audited Results | |
2024-02-09 | Quarterly Results |
Camlin Fine Sciences F&O
About Camlin Fine Sciences
- NSE Symbol
- CAMLINFINE
- BSE Symbol
- 532834
- Chairman & Managing Director
- Mr. Ashish Dandekar
- ISIN
- INE052I01032
Similar Stocks to Camlin Fine Sciences
Camlin Fine Sciences FAQs
Camlin Fine Sciences share price is ₹125 As on 21 December, 2024 | 18:08
The Market Cap of Camlin Fine Sciences is ₹2095.7 Cr As on 21 December, 2024 | 18:08
The P/E ratio of Camlin Fine Sciences is -9.4 As on 21 December, 2024 | 18:08
The PB ratio of Camlin Fine Sciences is 2.6 As on 21 December, 2024 | 18:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.